FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076336 [Registered on: 06/11/2024] Trial Registered Prospectively
Last Modified On: 01/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare the effect of Shigru Kwatha and Gokshuradi Guggulu in Mutrashmari (Urolithiasis) 
Scientific Title of Study   Comparative Clinical Evaluation of Shigru Kwatha and Gokshuradi Guggulu in Mutrashmari(Urolithiasis) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shubham Gaur 
Designation  Pg scholar 
Affiliation  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  OPD 15, Department of Shalya-Tantra, Patanjali ayurved hospital,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase 1, Roorkee road, Haridwar, Uttarakhand, India 249405 India

Hardwar
UTTARANCHAL
249405
India 
Phone  8954720047  
Fax    
Email  drshubhamgaur123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Saurabh Sharma 
Designation  Associate Pofessor 
Affiliation  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  OPD 15, Department of Shalya-Tantra, Patanjali ayurved hospital,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase 1, Roorkee road, Haridwar, Uttarakhand, India 249405

Hardwar
UTTARANCHAL
249405
India 
Phone  7020108714  
Fax    
Email  surgeonsaurabh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Shubham Gaur 
Designation  Pg scholar 
Affiliation  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  OPD 15, Department of Shalya-Tantra, Patanjali ayurved hospital,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase 1, Roorkee road, Haridwar, Uttarakhand, India 249405 India

Hardwar
UTTARANCHAL
249405
India 
Phone  8954720047  
Fax    
Email  drshubhamgaur123@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Yogpeeth phase- 1, Roorkee Road,Haridwar, India - 249405 
 
Primary Sponsor  
Name  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan 
Address  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan ,Haridwar,Uttarakhand ,India 249405 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shubham Gaur  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan  OPD 15, Department of Shalya-Tantra, Patanjali ayurved hospital,Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase 1, Roorkee road, Haridwar, Uttarakhand, India 249405
Hardwar
UTTARANCHAL 
8954720047

drshubhamgaur123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N22||Calculus of urinary tract in diseases classified elsewhere. Ayurveda Condition: ASMARI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shigru Kwatha, Reference: Brihat Nighantu Ratnakar Ashmarirogakarmavipaak pancham bhaag, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Anushnsheet jal), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Goshuradi Guggulu, Reference: Madhav nidan madhyam khand, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -anushnasheet jal), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  a) Patients willing to undergo trial and ready to give informed and written consent.
b) Patients of both sexes, irrespective of religion, socioeconomic status occupation will be taken.
d) Radiological evidence of (upto 15 mm) in kidney, ureter, urinary bladder & urethra.
e) Classical symptoms of Ashmari. 
 
ExclusionCriteria 
Details  a) Patients does not willing to undergo trial and ready to give informed and
written consent.
b) Complications related to Kidneys/ Ureter / Bladder like - Acute Renal
Failure, Chronic Renal Failure, Polycystic Kidney diseases, Impaired Renal
function, etc.
(c) Patients of Ashmari having systemic diseases like RHD ,AIDS
(Acquired immune deficiency syndrome).Other chronic diseases like TB (Tuberculosis), Hepatitis etc. will be
excluded.
d) Pregnant women and lactating mothers will be excluded.
e) Patients will be dropped if they develop any complications during the course
will also be excluded.
f) Calculi size more than 15 mm.
g) Patients having Moderate or severe Hydronephrosis will be excluded. 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
A) Subjective parameters: -
a) Pain
b) Burning micturition
c) Dysuria
d) Frequency of micturition
e) Hematuria 
3 months 
 
Secondary Outcome  
Outcome  TimePoints 
B) OBJECTIVE PARAMETERS:
a)Number of calculi
b)Size of calculus (according to USG before and after treatment).
c)Site of calculus 
3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   09/11/2024 
Date of Study Completion (India) 15/08/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 15/08/2025 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is a comparative clinical evaluation of Shigru Kwatha and Gokshuradi Guggulu in Murtrashmari (Urolithiasis).This will be conducted on 60 randomly selected patients from OPD/IPD of Shalya Tantra Department of Patanjali Bhartiya Ayurvigyan
Evam Anusandhan Sansthan, Haridwar. Patients will be divided into two groups- 30 patients will be administered with Shigru Kwatha orally and 30 patients will be administered with Gokshuadi Guggulu orally. First follow up will be after 30 days of treatment and
second follow up will be after 60 days of treatment and third follow up after 90 days of treatment.Assesment will be done on the basis ofsubjective and objective parameters as discussed earlier.
 
Close